| RS1193918618 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1193948667 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS1193951296 |
DPP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hatipoglu immunodeficiency syndrome, Hatipoglu immunodeficiency syndrome |
| RS1193962006 |
SCN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 5, Undetermined early-onset epileptic encephalopathy |
| RS1193996130 |
IQCB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Senior-Loken syndrome 5 |
| RS1193998170 |
NDUFAF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 17 |
| RS1194018304 |
ATP8B1
|
Health Risk |
Likely pathogenic |
ATP8B1-related disorder, ATP8B1-related disorder |
| RS1194024312 |
COQ8A
|
Health Risk |
Likely pathogenic |
COQ8A-related disorder, Hepatocellular carcinoma |
| RS1194031580 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1194043670 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1194065369 |
MYO6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1194065564 |
GDF5
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1194072973 |
TTLL5
|
Health Risk |
Likely pathogenic |
— |
| RS1194084403 |
NHLRC1
|
Health Risk |
Likely pathogenic |
Lafora disease, Lafora disease |
| RS1194089098 |
PARN
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS1194108487 |
ZNF292
|
Health Risk |
Likely pathogenic |
— |
| RS1194131222 |
MKS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1194139877 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1194157372 |
WNK1
|
Health Risk |
Pathogenic |
Pseudohypoaldosteronism type 2C, Neuropathy |
| RS1194186968 |
ANKRD11
|
Health Risk |
Conflicting classifications of pathogenicity |
KBG syndrome, KBG syndrome |
| RS1194187379 |
TK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome, myopathic form |
| RS1194199486 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Inborn genetic diseases |
| RS1194223999 |
TERT
|
Health Risk |
Pathogenic/Likely pathogenic |
Acute myeloid leukemia, Idiopathic Pulmonary Fibrosis |
| RS1194226000 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1194234452 |
MED17
|
Health Risk |
Likely pathogenic |
— |
| RS1194236664 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1194239835 |
SNAPC4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with motor regression, progressive spastic paraplegia |
| RS1194259722 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS1194266904 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS1194269620 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1194279553 |
COL11A2
|
Health Risk |
Pathogenic |
— |
| RS1194283484 |
BLOC1S6
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 9, Hermansky-Pudlak syndrome 9 |
| RS1194286714 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile neuroaxonal dystrophy, Infantile neuroaxonal dystrophy |
| RS1194291909 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Weill-Marchesani syndrome, Glaucoma 3 |
| RS1194295774 |
NLRP2
|
Health Risk |
Pathogenic |
Oocyte/zygote/embryo maturation arrest 18, Oocyte/zygote/embryo maturation arrest 18 |
| RS1194309134 |
EMILIN1
|
Health Risk |
Pathogenic |
Neuronopathy, distal hereditary motor |
| RS1194309507 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease type 2 |
| RS1194327802 |
MMUT
|
Health Risk |
Likely pathogenic |
— |
| RS1194329020 |
WDR81
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia, intellectual disability |
| RS1194330942 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Hypertrichotic osteochondrodysplasia Cantu type |
| RS1194348744 |
EXT2
|
Health Risk |
Likely pathogenic |
Exostoses, multiple |
| RS1194358112 |
DSP
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS1194378231 |
GHR
|
Health Risk |
Pathogenic |
Laron-type isolated somatotropin defect, Growth hormone insensitivity syndrome |
| RS1194387834 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS1194388677 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS1194408714 |
THOC6
|
Health Risk |
Pathogenic |
THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome, THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome |
| RS1194444860 |
P3H1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1194453106 |
CD40
|
Health Risk |
Likely pathogenic |
— |
| RS1194458561 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1194460219 |
DNAI2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1194460500 |
SYNE1
|
Health Risk |
Likely pathogenic |
— |
| RS1194477276 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS1194483230 |
ADK
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1194494050 |
ADA
|
Health Risk |
Likely pathogenic |
SCID due to ADA deficiency, delayed onset |
| RS119450940 |
ADSL
|
Health Risk |
Pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS119450941 |
ADSL
|
Health Risk |
Pathogenic |
Adenylosuccinate lyase deficiency, Inborn genetic diseases |
| RS119450942 |
ADSL
|
Health Risk |
Pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS119450943 |
ADSL
|
Health Risk |
Pathogenic/Likely pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS119450944 |
ADSL
|
Health Risk |
Pathogenic/Likely pathogenic |
Adenylosuccinate lyase deficiency, ADSL-related disorder |
| RS119450945 |
ADSL
|
Health Risk |
Pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS119451946 |
PINK1
|
Health Risk |
Pathogenic |
Parkinson disease, autosomal recessive early-onset |
| RS1194524772 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1194536394 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome 2, Noonan syndrome 2 |
| RS119454947 |
CACNA1H
|
Health Risk |
risk factor |
Epilepsy, childhood absence |
| RS119455951 |
GORAB
|
Health Risk |
Pathogenic |
Geroderma osteodysplastica, GORAB-related disorder |
| RS119455952 |
GORAB
|
Health Risk |
Pathogenic/Likely pathogenic |
Geroderma osteodysplastica, Geroderma osteodysplastica |
| RS119455953 |
TPP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis |
| RS119455954 |
TPP1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis |
| RS119455955 |
TPP1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis |
| RS119455956 |
TPP1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Autosomal recessive spinocerebellar ataxia 7 |
| RS119455957 |
TPP1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 2, Autosomal recessive spinocerebellar ataxia 7 |
| RS119455958 |
TPP1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis |
| RS119456959 |
NPHP3
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis 3, Nephronophthisis |
| RS119456960 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis 3, Nephronophthisis 3 |
| RS119456961 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis 3, Nephronophthisis |
| RS119456962 |
NPHP3
|
Health Risk |
Pathogenic |
NPHP3-related Meckel-like syndrome, Nephronophthisis |
| RS119456963 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal-hepatic-pancreatic dysplasia 1, NPHP3-related Meckel-like syndrome |
| RS119456964 |
NPHP3
|
Health Risk |
Pathogenic |
Renal-hepatic-pancreatic dysplasia 1, NPHP3-related Meckel-like syndrome |
| RS119456965 |
SIL1
|
Health Risk |
Pathogenic |
Marinesco-Sjögren syndrome, Marinesco-Sjögren syndrome |
| RS119456966 |
SIL1
|
Health Risk |
Pathogenic |
Marinesco-Sjögren syndrome, Marinesco-Sjögren syndrome |
| RS119456967 |
SIL1
|
Health Risk |
Pathogenic |
Marinesco-Sjögren syndrome, Marinesco-Sjögren syndrome |
| RS1194574169 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS1194583771 |
TG
|
Health Risk |
Pathogenic |
— |
| RS119458969 |
ETFA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric acidemia IIa, Multiple acyl-CoA dehydrogenase deficiency |
| RS119458970 |
ETFA
|
Health Risk |
Pathogenic |
Glutaric acidemia IIa, Multiple acyl-CoA dehydrogenase deficiency |
| RS119458971 |
ETFA
|
Health Risk |
Likely pathogenic |
Glutaric acidemia IIa, Multiple acyl-CoA dehydrogenase deficiency |
| RS1194593234 |
ALDH18A1
|
Health Risk |
Pathogenic |
ALDH18A1-related de Barsy syndrome, ALDH18A1-related de Barsy syndrome |
| RS119460972 |
XDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary xanthinuria type 1, Xanthinuria type II |
| RS119460973 |
OSTM1
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 5, Autosomal recessive osteopetrosis 5 |
| RS1194615408 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS119461974 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS119461975 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS119461976 |
SECISBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid hormone metabolism, abnormal 1 |
| RS119461977 |
SECISBP2
|
Health Risk |
Pathogenic |
Thyroid hormone metabolism, abnormal 1 |
| RS119462981 |
POMT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS119462982 |
POMT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS119462983 |
POMT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 |
| RS119462985 |
POMT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 |
| RS119462986 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 |
| RS119462987 |
POMT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 |